PLIMGOA Trademark

Trademark Overview


On Wednesday, May 2, 2018, a trademark application was filed for PLIMGOA with the United States Patent and Trademark Office. The USPTO has given the PLIMGOA trademark a serial number of 87904444. The federal status of this trademark filing is REGISTERED as of Tuesday, December 25, 2018. This trademark is owned by Glaxo Group Limited. The PLIMGOA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
plimgoa

General Information


Serial Number87904444
Word MarkPLIMGOA
Filing DateWednesday, May 2, 2018
Status700 - REGISTERED
Status DateTuesday, December 25, 2018
Registration Number5637303
Registration DateTuesday, December 25, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 9, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 11, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Monday, December 25, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 25, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, October 9, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 9, 2018PUBLISHED FOR OPPOSITION
Wednesday, September 19, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 5, 2018ELECTRONIC RECORD REVIEW COMPLETE
Friday, August 24, 2018ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, August 23, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 23, 2018ASSIGNED TO EXAMINER
Friday, May 11, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 5, 2018NEW APPLICATION ENTERED